Literature DB >> 24754826

Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Ivan O Rosas1, Paul F Dellaripa, David J Lederer, Dinesh Khanna, Lisa R Young, Fernando J Martinez.   

Abstract

Population-based, longitudinal studies spanning decades linking risk factors in childhood, adolescence and early adulthood to incident clinical interstitial lung disease (ILD) events in late adulthood have not been performed. In addition, no observational or randomized clinical trials have been conducted; therefore, there is presently no evidence to support the notion that reduction of risk factor levels in early life prevents ILD events in adult life. Primary prevention strategies are host-directed interventions designed to modify adverse risk factors (i.e., smoking) with the goal of preventing the development of ILD, whereas primordial prevention for ILD can be defined as the elimination of external risk factors (i.e., environmental pollutants). As no ILD primary prevention studies have been previously conducted, we propose that research studies that promote implementation of primary prevention strategies could, over time, make a subset of ILD preventable. Herein, we provide a number of initial steps required for the future implementation of prevention strategies; this statement discusses the rationale and available evidence that support potential opportunities for primordial and primary prevention, as well as fertile areas for future research of preventive intervention in ILD.

Entities:  

Mesh:

Year:  2014        PMID: 24754826      PMCID: PMC4112506          DOI: 10.1513/AnnalsATS.201312-429LD

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  100 in total

1.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

2.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

4.  Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease.

Authors:  Laurent Savale; Ari Chaouat; Sylvie Bastuji-Garin; Elisabeth Marcos; Laurent Boyer; Bernard Maitre; Mourad Sarni; Bruno Housset; Emmanuel Weitzenblum; Mireille Matrat; Philippe Le Corvoisier; Dominique Rideau; Jorge Boczkowski; Jean-Luc Dubois-Randé; Christos Chouaid; Serge Adnot
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

5.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

6.  Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.

Authors:  Philip J Clements; Michael D Roth; Robert Elashoff; Donald P Tashkin; Jonathan Goldin; Richard M Silver; Mildred Sterz; James R Seibold; Dean Schraufnagel; Robert W Simms; Marcy Bolster; Robert A Wise; Virginia Steen; M D Mayes; Kari Connelly; Mark Metersky; Daniel E Furst
Journal:  Ann Rheum Dis       Date:  2007-05-07       Impact factor: 19.103

7.  Pulmonary involvement in rheumatoid arthritis.

Authors:  P Cervantes-Perez; A H Toro-Perez; P Rodriguez-Jurado
Journal:  JAMA       Date:  1980-05-02       Impact factor: 56.272

8.  A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.

Authors:  Virginia Steen; Robyn T Domsic; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2012-09

9.  MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Ivan O Rosas; Thomas J Richards; Kazuhisa Konishi; Yingze Zhang; Kevin Gibson; Anna E Lokshin; Kathleen O Lindell; Jose Cisneros; Sandra D Macdonald; Annie Pardo; Frank Sciurba; James Dauber; Moises Selman; Bernadette R Gochuico; Naftali Kaminski
Journal:  PLoS Med       Date:  2008-04-29       Impact factor: 11.069

10.  Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope.

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Shoji Sugii; Jun Ohashi; Toshihiro Matsui; Tatsuoh Ikenaka; Hisanori Nakayama; Atsushi Hashimoto; Hirokazu Takaoka; Yoshiyuki Arinuma; Yuko Okazaki; Hidekazu Futami; Akiko Komiya; Naoshi Fukui; Tadashi Nakamura; Kiyoshi Migita; Akiko Suda; Shouhei Nagaoka; Naoyuki Tsuchiya; Shigeto Tohma
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more
  22 in total

1.  Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis.

Authors:  Athol U Wells; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2016-01-15       Impact factor: 21.405

2.  High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Elana J Bernstein; Eric A Hoffman; Imaani J Easthausen; Karen Hinckley Stukovsky; Arindam RoyChoudhury; Erin D Michos; Ganesh Raghu; Steven M Kawut; David J Lederer
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

3.  Reply: primary and secondary prevention of chronic obstructive pulmonary disease: where to next?

Authors:  James P Kiley; Gary H Gibbons
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

Review 4.  Executive Summary: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  William W Busse; Serpil C Erzurum; Carol J Blaisdell; Patricia Noel
Journal:  Ann Am Thorac Soc       Date:  2014-04

5.  Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Authors:  Tracy J Doyle; Avignat S Patel; Hiroto Hatabu; Mizuki Nishino; Guodong Wu; Juan C Osorio; Maria F Golzarri; Andres Traslosheros; Sarah G Chu; Michelle L Frits; Christine K Iannaccone; Diane Koontz; Carl Fuhrman; Michael E Weinblatt; Souheil Y El-Chemaly; George R Washko; Gary M Hunninghake; Augustine M K Choi; Paul F Dellaripa; Chester V Oddis; Nancy A Shadick; Dana P Ascherman; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

6.  Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.

Authors:  Leticia Kawano-Dourado; Tracy J Doyle; Karina Bonfiglioli; Márcio V Y Sawamura; Renato H Nakagawa; Fábio E Arimura; Hye J Lee; Diana Arrais de Souza Rangel; Cleonice Bueno; Carlos R R Carvalho; Maria Laura Sabbag; Camila Molina; Ivan O Rosas; Ronaldo A Kairalla
Journal:  Chest       Date:  2020-05-16       Impact factor: 9.410

7.  The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Rachel K Putman; Jorge Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Acad Radiol       Date:  2016-12-15       Impact factor: 3.173

8.  Rice Consumption and Subclinical Lung Disease in US Adults: Observational Evidence From the Multi-Ethnic Study of Atherosclerosis.

Authors:  Tiffany R Sanchez; Elizabeth C Oelsner; David J Lederer; Christian M Lo Cascio; Miranda R Jones; Maria Grau-Perez; Kevin A Francesconi; Walter Goessler; Matthew S Perzanowski; R Graham Barr; Ana Navas-Acien
Journal:  Am J Epidemiol       Date:  2019-09-01       Impact factor: 4.897

9.  Reference values for high attenuation areas on chest CT in a healthy, never-smoker, multi-ethnic sample: The MESA study.

Authors:  Imaani Easthausen; Anna Podolanczuk; Eric Hoffman; Steven Kawut; Elizabeth Oelsner; John S Kim; Ganesh Raghu; Karen Hinckley Stukovsky; Susan Redline; Robyn L McClelland; R Graham Barr; David J Lederer
Journal:  Respirology       Date:  2020-02-17       Impact factor: 6.424

10.  Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Claire F McGroder; Carrie P Aaron; Suzette J Bielinski; Steven M Kawut; Russell P Tracy; Ganesh Raghu; R Graham Barr; David J Lederer; Anna J Podolanczuk
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.